期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

谈联合降压新趋势——单片复方制剂

暂未订购
导出
摘要 高血压是心脑血管疾病的重要危险因子。降压可明显减少心脑血管疾病的风险。然而在降压过程中,降压达标率低一直是我们临床医生面临的严峻问题。大多数高血压患者为控制血压,须使用两种或以上降压药。基于此,美国预防、检测、
作者 徐辉
机构地区 浙江省嘉兴市秀洲区高照街道卫生院
出处 《中国乡村医药》 2012年第5期52-52,共1页
关键词 降压药 复方制剂 心脑血管疾病 高血压患者 危险因子 控制血压
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献4

二级参考文献12

  • 1Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension, 2003,42:239-246.
  • 2Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet,2000,29;356:366-372.
  • 3Howe P, Phillips P, Saini R, et al.The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group. Clin Exp Hypertens. 1999,21:1373-1396.
  • 4中国高血压防治指南起草委员会.1999中国高血压防治指南[J].高血压杂志,2000,8:94-112.
  • 5European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens,2003,21:1011-1053.
  • 6Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.Lancet. 1998,351:1755-1762.
  • 7.The task force of the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)[].Journal of Hypertension.2007
  • 8Yusuf S,Sleight P,Pogue J,et al.Effects of anangiotensin-converting-enzyme inhibitor,ramipril,on cardiovascularevents in high-risk patients The Heart Outcomes Prevention EvaluationStudy Investigators[].The New England Journal of Medicine.2000
  • 9Fox KM.Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised,double-blind,placebo-controlled,multicentre trial (the EUROPA study)[].The Lancet.2003
  • 10Braunwald E,DomanskiM J,Fowler SE,et al.Angiotensin- converting-enzyme inhibition in stable coronary artery disease[].The New England Journal of Medicine.2004

共引文献114

中国乡村医药
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部